Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Artificial Hip and Knee Joints Market Size & Growth Forecast 2026–2035, By Segments (Site, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 12373| Published Date: Apr-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Artificial Hip and Knee Joints Market size was worth USD 13.18 Billion in 2025 and is poised to grow at a 2.9% CAGR between 2026 and 2035, crossing USD 17.54 Billion by 2035. The industry revenue for 2026 is assessed at USD 13.51 billion.

Base Year Value (2025)
USD 13.18 Billion
CAGR (2026-2035)
2.9%
Forecast Year Value (2035)
USD 17.54 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Artificial Hip and Knee Joints Market Intelligence Snapshot

Regional Market Dynamics

  • North America leads with 48.76% share due to high joint replacement volumes, advanced orthopedic care systems, and strong adoption of implant technologies across hospitals and specialty centers.
  • Asia Pacific is expanding at 3.31% CAGR, supported by improving surgical access, expanding hospital infrastructure, and rising adoption of joint replacement procedures in developing healthcare systems.

Segment Momentum

  • Knee Joints held a 60.14% share in 2025, supported by high replacement procedure volumes, established treatment pathways, and consistent implant utilization across routine orthopedic care.
  • Orthopedic Clinics are growing fastest as patients increasingly seek specialized musculoskeletal care, benefiting from focused expertise, streamlined referrals, and efficient follow-up within the joint replacement care pathway.

Market Expansion Drivers

  • Rising geriatric population and osteoarthritis prevalence driving demand for joint replacement procedures.
  • Advancements in minimally invasive orthopedic implants improving surgical outcomes and recovery times.
  • Increasing sports injuries and mobility disorders expanding orthopedic implant adoption across younger populations.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Top companies in the artificial hip and knee joints market include Zimmer Biomet Holdings, Inc. (United States), Stryker Corporation (United States), Johnson & Johnson (United States), Smith & Nephew plc (United Kingdom), Exactech, Inc (United States), Enovis Corporation (United States), Medacta International SA (Switzerland), MicroPort Scientific Corporation (China), Corentec Co., Ltd. (South Korea).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising geriatric population and osteoarthritis prevalence increasing demand for joint replacement procedures

As the elderly population grows, the artificial hip and knee joints market is seeing a larger pool of patients with progressive cartilage degeneration, reduced joint function, and chronic pain that no longer responds to medication or physical therapy. Osteoarthritis shifts treatment pathways toward surgical intervention when mobility loss begins to affect independence, which increases procedure volumes for hospitals and orthopedic centers. This dynamic is reinforcing market demand as healthcare providers expand joint replacement capacity, surgeons standardize implant-based treatment for late-stage disease, and patients increasingly view hip and knee arthroplasty as a practical solution for restoring movement and daily function.

Advancements in minimally invasive orthopedic implants improving surgical outcomes and recovery times

Design improvements in implant geometry, fixation methods, and surgical compatibility are changing how procedures are performed, supporting market expansion in the artificial hip and knee joints market by making joint replacement more acceptable to both surgeons and patients. Minimally invasive approaches typically reduce tissue disruption, shorten hospital stays, and improve early mobility, which influences hospital purchasing decisions and encourages wider adoption in facilities focused on efficiency and patient throughput. As recovery profiles improve, orthopedic specialists are more willing to recommend intervention earlier in the disease course, increasing market penetration for newer hip and knee implant systems.

Increasing sports injuries and mobility disorders expanding orthopedic implant adoption across younger populations

A rising incidence of ligament damage, cartilage injury, post-traumatic degeneration, and other mobility-limiting conditions is broadening the patient base for the artificial hip and knee joints market beyond traditional elderly cohorts. Younger patients tend to seek treatments that restore function, maintain activity levels, and limit long-term disability, prompting orthopedic surgeons to consider implant solutions in cases where reconstructive or conservative options are no longer sufficient. This is contributing to market size growth by shifting demand toward durable, performance-oriented hip and knee joint systems designed for higher activity expectations and longer functional use.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising geriatric population and osteoarthritis prevalence driving demand for joint replacement procedures 1.20% High North America, Europe High Near Term
Advancements in minimally invasive orthopedic implants improving surgical outcomes and recovery times 1.00% High North America, Asia Pacific High Mid Term
Increasing sports injuries and mobility disorders expanding orthopedic implant adoption across younger populations 0.90% Moderate North America, Europe Medium Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
48.76% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 48.76% share of the artificial hip and knee joints market in 2025, supported by a mature orthopedic care ecosystem, high procedure volumes, and broad access to joint replacement services across hospitals and specialty centers. The region’s leadership is supported by established surgeon expertise, strong utilization of advanced implant technologies, and a large patient pool undergoing elective and medically necessary joint reconstruction. In practice, this creates a steady flow of primary and revision procedures, while integrated reimbursement and care delivery systems help maintain consistent demand for artificial hip and knee joints.

Asia Pacific is projected to expand at a 3.31% CAGR over the forecast period, with growth in the artificial hip and knee joints market being propelled by rising access to orthopedic treatment and increasing adoption of joint replacement procedures across developing healthcare systems. Demand is accelerating as more patients enter formal surgical pathways, supported by improving hospital infrastructure and broader availability of implant procedures in urban and expanding secondary care settings. The region’s growth pattern reflects practical adoption gains as providers scale surgical capacity and more patients seek treatment for mobility-limiting joint conditions.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Rehabilitation-Oriented Demand

Germany emphasizes joint replacement solutions that support faster recovery and long-term mobility improvement. Demand in Germany increasingly centers on high-quality hip and knee implants that complement the country's established orthopedic rehabilitation and post-surgical care infrastructure.

France 🇫🇷

Mobility Restoration Priority

France maintains steady demand for artificial hip and knee joints through continued emphasis on managing age-related musculoskeletal conditions. Healthcare providers in France increasingly prioritize implant solutions that deliver reliable performance and support efficient postoperative recovery pathways.

Italy 🇮🇹

Elective Orthopedic Demand

Italy's market for artificial hip and knee joints is supported by sustained demand for elective orthopedic procedures among aging patient groups. Hospitals in Italy are increasingly seeking implant systems that balance long-term functionality with procedural efficiency and streamlined surgical workflows.

Japan 🇯🇵

Longevity-Driven Procedures

Japan's aging population continues to sustain demand for hip and knee replacement procedures aimed at preserving mobility and quality of life. The market in Japan increasingly favors durable implants and surgical approaches that minimize recovery burdens for elderly patients.

South Korea 🇰🇷

Premium Procedure Expansion

South Korea is seeing increased adoption of advanced joint replacement procedures supported by sophisticated hospital infrastructure and patient awareness. Demand in South Korea increasingly focuses on modern implant technologies and surgical techniques that enhance procedural precision and patient satisfaction.

United States 🇺🇸

Advanced Implant Adoption

The U.S. artificial hip and knee joints market is characterized by strong uptake of technologically advanced implants and increasing demand for personalized joint replacement solutions. Providers in the U.S. continue to expand the use of robotic-assisted procedures and implants designed to improve long-term outcomes.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Artificial Hip and Knee Joints Market Share (%), Site, 2025

Knee Joints
Hip Joints

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Site Segment Analysis: Knee Joints (Largest Segment) vs Hip Joints (Fastest-Growing Segment)

Knee Joints held the strongest position in the artificial hip and knee joints market in 2025, accounting for a 60.14% share. This leadership is maintained through the high procedural volume associated with knee replacement, where patients often seek intervention to address mobility limitations that directly affect daily function. The artificial hip and knee joints market continues to see Knee Joints maintain scale because treatment pathways, surgical familiarity, and implant utilization are well established, helping providers manage demand efficiently across routine orthopedic care settings.

Hip Joints represent the fastest-growing segment in the artificial hip and knee joints market, underpinned by rising adoption where patients and surgeons prioritize restoration of movement, pain reduction, and improved post-procedure mobility. Growth is seeing wider adoption because hip replacement is increasingly aligned with evolving expectations for faster functional recovery and durable outcomes relative to non-surgical management in appropriate cases. This practical shift in treatment preference is helping Hip Joints expand faster than alternative site categories within the market.

End Use Segment Analysis: Hospitals & Surgery Centers (Largest Segment) vs Orthopedic Clinics (Fastest-Growing Segment)

Across the artificial hip and knee joints market, Hospitals & Surgery Centers led the end use segment in 2025 with a 67.61% share. Their dominance is anchored in the ability to handle full surgical workflows, including pre-operative assessment, operating room infrastructure, inpatient or same-day procedural management, and post-surgical monitoring. Hospitals & Surgery Centers retain the largest share because joint replacement procedures require coordinated clinical resources and surgical support systems that are more consistently available in these settings.

Orthopedic Clinics are the fastest-growing end use segment in the artificial hip and knee joints market as care delivery gradually shifts toward more specialized and streamlined musculoskeletal treatment environments. Their momentum reflects growing patient preference for focused orthopedic evaluation and follow-up within dedicated settings that can support faster referral pathways and more concentrated expertise. Compared with broader hospital-based channels, Orthopedic Clinics are gaining growth from their ability to serve as efficient access points in the joint replacement care continuum.

Segment Sub-Segment Largest Segment Fastest Growing
Site Hip Joints, Knee Joints Knee Joints Hip Joints
End Use Hospitals & Surgery Centers, Orthopedic Clinics, Others Hospitals & Surgery Centers Orthopedic Clinics
Competitive Landscape

Competitive Landscape and Market Positioning

Leading companies in the artificial hip and knee joints market:

1. Zimmer Biomet Holdings Inc. (United States)

2. Stryker Corporation (United States)

3. Johnson & Johnson (United States)

4. Smith & Nephew plc (United Kingdom)

5. Exactech Inc (United States)

6. Enovis Corporation (United States)

7. Medacta International SA (Switzerland)

8. MicroPort Scientific Corporation (China)

9. Corentec Co. Ltd. (South Korea)

Rising patient expectations for mobility restoration are fueling advancements in joint replacement technologies. Material enhancements are improving implant durability and biocompatibility outcomes. The artificial hip and knee joints market is progressing with a focus on long-term functional performance improvements.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Corentec Feb-24 Corentec received U.S. FDA clearance for the BENCOX Mirabo Z Cup Continuum hip implant component. The approval enables commercialization of the artificial hip cup in the U.S. market, strengthening Corentec’s presence in orthopedic implant systems and expanding its product offering in hip reconstruction solutions.
Medacta Group S.A. Oct-23 Medacta Group S.A. introduced the GMK SpheriKA femoral component designed for kinematic alignment in total knee replacement procedures. The product enhances surgical precision in knee arthroplasty by supporting alignment-specific implantation strategies aimed at improving procedural outcomes in joint reconstruction.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Artificial Hip and Knee Joints Market — Custom Segments

Segment Sub-Segment
No segment data available.

Artificial Hip and Knee Joints Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the market valuation of artificial hip and knee joints?

The market size of the artificial hip and knee joints is estimated at USD 13.51 billion in 2026.

What are the growth projections for the artificial hip and knee joints industry?

Artificial Hip and Knee Joints Market size is predicted to expand from USD 13.18 billion in 2025 to USD 17.54 billion by 2035 with growth underpinned by a CAGR above 2.9% between 2026 and 2035.

How are demographic and disease trends driving demand in the artificial hip and knee joints market?

An expanding elderly population and increasing osteoarthritis prevalence are raising joint replacement procedure volumes as providers and patients increasingly rely on implant-based treatment to restore mobility and daily function.

How are advances in implant design expanding adoption in the artificial hip and knee joints market?

Minimally invasive implant innovations improve recovery, reduce tissue disruption, and enhance surgical efficiency, encouraging broader hospital adoption and supporting earlier intervention for patients requiring joint replacement.

Why do Knee Joints account for the largest share of the artificial hip and knee joints market?

Knee Joints held a 60.14% share in 2025, supported by high replacement procedure volumes, established treatment pathways, and consistent implant utilization across routine orthopedic care.

Why are Orthopedic Clinics the fastest-growing end-use segment in the artificial hip and knee joints market?

Orthopedic Clinics are growing fastest as patients increasingly seek specialized musculoskeletal care, benefiting from focused expertise, streamlined referrals, and efficient follow-up within the joint replacement care pathway.

Why is North America the largest market for artificial hip and knee joints?

North America leads with 48.76% share due to high joint replacement volumes, advanced orthopedic care systems, and strong adoption of implant technologies across hospitals and specialty centers.

What is driving Asia Pacific growth in artificial hip and knee joints?

Asia Pacific is expanding at 3.31% CAGR, supported by improving surgical access, expanding hospital infrastructure, and rising adoption of joint replacement procedures in developing healthcare systems.

Which companies dominate the artificial hip and knee joints landscape?

Top companies in the artificial hip and knee joints market include Zimmer Biomet Holdings, Inc. (United States), Stryker Corporation (United States), Johnson & Johnson (United States), Smith & Nephew plc (United Kingdom), Exactech, Inc (United States), Enovis Corporation (United States), Medacta International SA (Switzerland), MicroPort Scientific Corporation (China), Corentec Co., Ltd. (South Korea).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →